DAYS
Fig. 1. Subject's daily caffeine intake (mg) during baseline, treatment, and follow-up. The criterion level
for each treatment phase was 102 mg of caffeine less than the previous treatment phase. Solid horizontal lines
indicate the criterion level for each phase. Broken horizontal lines indicate the mean for each condition.